Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.18 | 6e-06 |
mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-06 |
mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.14 | 6e-06 |
mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.17 | 6e-06 |
mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.14 | 1e-05 |
mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.14 | 1e-05 |
mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.13 | 3e-05 |